Modeling madness in mice: one piece at a time
- PMID:17015235
- DOI: 10.1016/j.neuron.2006.09.023
Modeling madness in mice: one piece at a time
Abstract
Mouse models that recapitulate the full phenotypic spectrum of a psychiatric disorder, such as schizophrenia, are impossible. However, a more piecemeal recreation of phenotypic components is feasible and promises to harness the power of animal models using approaches that are either off limits or confounded by drug treatment in humans. In that context, animal models will have a central and indispensable role in the process of discovering the causes of psychiatric disorders and generating novel, mechanism-based treatments. Here, we discuss current approaches used to generate animal models of psychiatric disorders, address the different components of these disorders that can be modeled in animals, and describe currently available analytical tools. We also discuss accumulating empirical data and take an in-depth look at what we believe to be the future of animal models made possible by recent advances in psychiatric genetics.
Similar articles
- Impact of brain-behavior phenotypying of genetically-engineered mice on research of neuropsychiatric disorders.Takao K, Yamasaki N, Miyakawa T.Takao K, et al.Neurosci Res. 2007 Jun;58(2):124-32. doi: 10.1016/j.neures.2007.02.009. Epub 2007 Feb 20.Neurosci Res. 2007.PMID:17524507Review.
- Transgenic mouse models of dopamine deficiency.Chen L, Zhuang X.Chen L, et al.Ann Neurol. 2003;54 Suppl 6:S91-102. doi: 10.1002/ana.10655.Ann Neurol. 2003.PMID:12891659Review.
- Transgenic modeling of neuropsychiatric disorders.Campbell IL, Gold LH.Campbell IL, et al.Mol Psychiatry. 1996 May;1(2):105-20.Mol Psychiatry. 1996.PMID:9118320Review.
- Mouse models of madness.Brown V, Smith D.Brown V, et al.Mol Psychiatry. 1999 Sep;4(5):400-2.Mol Psychiatry. 1999.PMID:10523806Review.
- Genetics of behavioural domains across the neuropsychiatric spectrum; of mice and men.Kas MJ, Fernandes C, Schalkwyk LC, Collier DA.Kas MJ, et al.Mol Psychiatry. 2007 Apr;12(4):324-30. doi: 10.1038/sj.mp.4001979. Epub 2006 Nov 21.Mol Psychiatry. 2007.PMID:17389901Review.
Cited by
- Neurodevelopmental effects of insulin-like growth factor signaling.O'Kusky J, Ye P.O'Kusky J, et al.Front Neuroendocrinol. 2012 Aug;33(3):230-51. doi: 10.1016/j.yfrne.2012.06.002. Epub 2012 Jun 16.Front Neuroendocrinol. 2012.PMID:22710100Free PMC article.Review.
- Disruption of Arp2/3 results in asymmetric structural plasticity of dendritic spines and progressive synaptic and behavioral abnormalities.Kim IH, Racz B, Wang H, Burianek L, Weinberg R, Yasuda R, Wetsel WC, Soderling SH.Kim IH, et al.J Neurosci. 2013 Apr 3;33(14):6081-92. doi: 10.1523/JNEUROSCI.0035-13.2013.J Neurosci. 2013.PMID:23554489Free PMC article.
- Growth arrest specific gene 7 is associated with schizophrenia and regulates neuronal migration and morphogenesis.Zhang Z, Zheng F, You Y, Ma Y, Lu T, Yue W, Zhang D.Zhang Z, et al.Mol Brain. 2016 May 18;9(1):54. doi: 10.1186/s13041-016-0238-y.Mol Brain. 2016.PMID:27189492Free PMC article.
- Adenosine augmentation ameliorates psychotic and cognitive endophenotypes of schizophrenia.Shen HY, Singer P, Lytle N, Wei CJ, Lan JQ, Williams-Karnesky RL, Chen JF, Yee BK, Boison D.Shen HY, et al.J Clin Invest. 2012 Jul;122(7):2567-77. doi: 10.1172/JCI62378. Epub 2012 Jun 18.J Clin Invest. 2012.PMID:22706302Free PMC article.
- Developmental etiology for neuroanatomical and cognitive deficits in mice overexpressing Galphas, a G-protein subunit genetically linked to schizophrenia.Kelly MP, Stein JM, Vecsey CG, Favilla C, Yang X, Bizily SF, Esposito MF, Wand G, Kanes SJ, Abel T.Kelly MP, et al.Mol Psychiatry. 2009 Apr;14(4):398-415, 347. doi: 10.1038/mp.2008.124. Epub 2008 Nov 25.Mol Psychiatry. 2009.PMID:19030002Free PMC article.
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical